XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-based Compensation
 3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

NOTE 7 —Stock-based Compensation

 

Stock-based compensation expense for the three months ended March 31, 2023 and 2022 is as follows:

 

   2023   2022 
   Three Months Ended 
   March 31, 
   2023   2022 
Cost of revenues  $152   $11 
Sales and marketing   46    26 
General and administrative   111    225 
Research and development   —    21 
Stock-based compensation expenses  $309   $283 

 

Stock Options:

 

Stock option activity for the three months ended March 31, 2023, is set forth in the table below:

 Summary of Stock Option Activity

 

       Weighted average  

Weighted average remaining contractual

   Aggregate 
       exercise price   life   Intrinsic 
   Options   per share   (in years)   Value* 
Outstanding at January 1, 2023   4,476,215   $0.95    9.76   $358 
Options granted   1,253,000   $0.50           
Options exercised   —                
Options forfeited   —                
Options expired   —                
Outstanding at March 31, 2023   5,729,215   $0.85    9.56   $3,256 
                     
Exercisable at March 31, 2023   55,496   $39.22    5.04   $0 

 

*The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.

 

As of March 31, 2023, there was approximately $2,266 of unamortized stock-based compensation cost related to unvested stock options and RSU’s, which is expected to be recognized over a weighted average period of 2.32 years.

 

Restricted Stock Units:

 

Restricted stock units’ (“RSU”) activity for the three months ended March 31, 2023, is set forth in the table below:

 

   RSUs 
Outstanding at January 1, 2023   860,888 
Granted   — 
Released   — 
Forfeited   — 
Outstanding at March 31, 2023   860,888